Trump Plans to Impose Tariffs on Generic Drugs

The Trump administration has announced its intention to impose tariffs on generic drugs, a move that has been long anticipated but never executed. This decision, if implemented, could significantly increase the cost of medications for consumers, especially for those relying on affordable generics. While the administration has frequently spoken about these tariffs, the actual execution raises questions about regulatory processes and the potential impact on healthcare affordability. For a detailed look at the implications, it's worth checking out the full article in The New York Times.